Rationale and design of two, phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory and unexplained chronic cough
| Autor: | David Muccino, George Philip, A.H. Morice, S.S. Birring, L. Mcgarvey, P.V. Dicpinigaitis, I.D. Pavord, A.M. Tershakovec, M.M. Kitt, C. Assaid, J.A. Smith |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | World Allergy Organization Journal, Vol 13, Iss 8, Pp 100203- (2020) |
| Druh dokumentu: | article |
| ISSN: | 1939-4551 |
| DOI: | 10.1016/j.waojou.2020.100203 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|